|
DE69833791D1
(de)
*
|
1997-11-24 |
2006-05-04 |
Scripps Research Inst |
Hemmer der "gap junction communication"
|
|
US6858649B1
(en)
*
|
1998-04-30 |
2005-02-22 |
The Scripps Research Institute |
Selective potentiation of serotonin receptor subtypes
|
|
GB9926833D0
(en)
*
|
1999-11-15 |
2000-01-12 |
Univ Sunderland |
Compositions
|
|
WO2002062963A2
(en)
*
|
2001-02-08 |
2002-08-15 |
Nps Pharmaceuticals, Inc. |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
IL158131A0
(en)
|
2001-03-27 |
2004-03-28 |
Univ California |
Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
|
|
US20050054730A1
(en)
*
|
2001-03-27 |
2005-03-10 |
The Regents Of The University Of California |
Compounds, compositions and treatment of oleoylethanolamide-like modulators of PPARalpha
|
|
WO2003011220A2
(en)
*
|
2001-07-31 |
2003-02-13 |
The Scripps Research Institute |
Animal model for fatty acid amide-related neurobehaviors
|
|
ES2186576B1
(es)
*
|
2001-10-11 |
2004-09-16 |
Universitat De Les Illes Balears |
Acido 2-hidroxioleico para utilizar como medicamento.
|
|
US20040063726A1
(en)
*
|
2002-02-08 |
2004-04-01 |
Artman Linda D |
Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same
|
|
EA010267B1
(ru)
*
|
2002-10-07 |
2008-06-30 |
Те Риджентс Оф Те Юниверсити Оф Калифорния |
Модуляция тревоги через блокаду гидролиза анандамида
|
|
US7765162B2
(en)
*
|
2002-10-07 |
2010-07-27 |
Mastercard International Incorporated |
Method and system for conducting off-line and on-line pre-authorized payment transactions
|
|
JP2007509066A
(ja)
*
|
2003-10-16 |
2007-04-12 |
ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
体脂肪を減らし、食欲を抑制し、脂肪酸代謝を調節するための食物および他の組成物、化合物ならびに方法
|
|
NZ590148A
(en)
|
2004-12-30 |
2012-04-27 |
Janssen Pharmaceutica Nv |
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
|
|
WO2006116773A2
(en)
*
|
2005-04-28 |
2006-11-02 |
The Regents Of The University Of California |
Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-related disorders
|
|
US7541359B2
(en)
|
2005-06-30 |
2009-06-02 |
Janssen Pharmaceutica N.V. |
N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase
|
|
EP1954137A4
(en)
|
2005-11-18 |
2008-12-17 |
Janssen Pharmaceutica Nv |
2-KETO-OXAZOLE AS MODULATORS OF FATTY ACID AMIDHYDROLASE
|
|
EP1983994B1
(en)
|
2006-02-17 |
2015-09-30 |
The Scripps Research Institute |
Oxazole ketones as modulators of fatty acid amide hydrolase
|
|
WO2007140005A2
(en)
*
|
2006-05-26 |
2007-12-06 |
Janssen Pharmaceutica N.V. |
Oxazolyl piperidine modulators of fatty acid amide hydrolase
|
|
WO2008030752A2
(en)
*
|
2006-09-07 |
2008-03-13 |
N.V. Organon |
Methods for determining effective doses of fatty acid amide hydrolase inhibitors in vivo
|
|
JO3598B1
(ar)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
CA2674359A1
(en)
*
|
2006-11-20 |
2008-05-29 |
N.V. Organon |
Metabolically-stabilized inhibitors of fatty acid amide hydrolase
|
|
CA2721060A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
ES2342997B1
(es)
*
|
2008-12-09 |
2011-06-06 |
Universitat De Les Illes Balears |
Alpha derivados de acidos grasos cis-monoinsaturados para ser usados como medicamento.
|
|
WO2010118159A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
WO2010118155A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
|
US9062116B2
(en)
|
2009-04-23 |
2015-06-23 |
Infinity Pharmaceuticals, Inc. |
Anti-fatty acid amide hydrolase-2 antibodies and uses thereof
|
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
|
US20120225097A1
(en)
|
2009-11-12 |
2012-09-06 |
Hawryluk Natalie A |
Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah)
|
|
RU2015143910A
(ru)
|
2010-02-03 |
2018-12-28 |
Инфинити Фармасьютикалз, Инк. |
Ингибиторы амид-гидролазы жирных кислот
|
|
UA108233C2
(uk)
|
2010-05-03 |
2015-04-10 |
|
Модулятори активності гідролази амідів жирних кислот
|
|
EP3362462B1
(en)
|
2015-10-12 |
2021-07-21 |
Advanced Cell Diagnostics, Inc. |
In situ detection of nucleotide variants in high noise samples, and compositions and methods related thereto
|
|
WO2021097069A1
(en)
*
|
2019-11-12 |
2021-05-20 |
The Trustees Of The University Of Pennsylvania |
Oleic acid derivatives as treatments for friedreich ataxia and inhibitors of ferroptosis
|
|
CN111004125B
(zh)
*
|
2019-12-24 |
2022-11-22 |
东华理工大学 |
一种缩醛或缩酮化合物的制备方法
|
|
WO2021152201A2
(es)
|
2020-01-29 |
2021-08-05 |
Universitat De Les Illes Balears |
Metabolitos de ácidos grasos alfa-hidroxilados, usos médicos de los mismos y uso como biomarcadores
|